Insulet | PODD - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 6.8B 1.72B 2026-03
Align Technology USD 1.06B 35.07M 2026-03
AtriCure USD 146.16M 21.26M 2026-03
Avanos Medical USD 65.6M 24.2M 2026-03
Baxter International USD 2.02B 51M 2026-03
Becton, Dickinson and Co. USD 813M 73M 2026-03
Boston Scientific USD 1.45B 512M 2026-03
Cardinal Health USD 3.94B 1.16B 2026-03
Cooper Companies USD 124.9M 14.3M 2025-12
Dexcom USD 1.12B 200.5M 2026-03
Edwards Lifesciences USD 2.4B 538M 2026-03
Eli Lilly USD 5.28B 1.99B 2026-03
Globus Medical USD 560.95M 34.79M 2026-03
ICU Medical USD 307.96M 8.23M 2025-12
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 480.4M 235.7M 2026-03
Integra LifeSciences USD 236.81M 1.76M 2026-03
J&J USD 21.69B 1.98B 2026-03
Medtronic USD 1.15B 135M 2025-12
Merit Medical Systems USD 488.08M 41.68M 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Solventum Corp USD 561M 317M 2026-03
Stryker USD 2.88B 1.13B 2026-03
Tandem Diabetes Care USD 179.32M 88.69M 2026-03
Teleflex USD 309.41M 69.15M 2026-03
West Pharmaceutical Services USD 521.4M 269.9M 2026-03
Zimmer Biomet Holdings USD 424.2M 167.7M 2026-03